Jun 10, 2016AAT Presentation14th International Symposium on Advances in Alzheimer Therapy, Athens, GreeceChristopher U. Missling, PhDView Presentation
14th International Symposium on Advances in Alzheimer Therapy, Athens, GreeceChristopher U. Missling, PhDView Presentation
New Phase IIb/III Clinical Data Demonstrates Over Three Years of Continuous Treatment with Oral Blarcamesine to Significantly Benefit Early Alzheimer’s Disease Patients
Anavex Life Sciences Reports Fiscal 2024 Fourth Quarter Financial Results and Provides Business Update
